Clinical Study on the Risk Factors for the Recurrence of Papillary Thyroid Carcinoma.

IF 2 4区医学 Q2 OTORHINOLARYNGOLOGY

Orl-Journal for Oto-Rhino-Laryngology Head and Neck Surgery Pub Date : 2023-01-01 DOI:10.1159/000528540

Takashi Masui, Shiori Adachi, Hirokazu Uemura, Takahiro Kimura, Tadashi Kitahara

{"title":"Clinical Study on the Risk Factors for the Recurrence of Papillary Thyroid Carcinoma.","authors":"Takashi Masui, Shiori Adachi, Hirokazu Uemura, Takahiro Kimura, Tadashi Kitahara","doi":"10.1159/000528540","DOIUrl":null,"url":null,"abstract":"Introduction: Papillary thyroid carcinoma is the most common endocrine malignancy and the most common type of thyroid cancer, accounting for approximately 85% of all thyroid cancer cases. It usually has a favorable course, with the 10-year survival rate exceeding 90%. However, the literature reports a recurrence rate of 7-23% after initial surgical treatment. It is important to consider medical treatment policies for this recurrence.Methods: In this study, we examined the risk factors for the recurrence of papillary thyroid carcinoma. We treated 274 patients with thyroid papillary carcinoma at our hospital between 2009 and 2018.Results: Recurrence occurred in 20 cases (7.3%). Lympho-vascular invasion and lateral cervical lymph node metastasis made significant independent contributions.Conclusion: The selection of the surgical mode should be based on the recurrence and after comprehensive consideration of the clinical features.","PeriodicalId":49717,"journal":{"name":"Orl-Journal for Oto-Rhino-Laryngology Head and Neck Surgery","volume":"85 2","pages":"104-108"},"PeriodicalIF":2.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orl-Journal for Oto-Rhino-Laryngology Head and Neck Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000528540","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Papillary thyroid carcinoma is the most common endocrine malignancy and the most common type of thyroid cancer, accounting for approximately 85% of all thyroid cancer cases. It usually has a favorable course, with the 10-year survival rate exceeding 90%. However, the literature reports a recurrence rate of 7-23% after initial surgical treatment. It is important to consider medical treatment policies for this recurrence.

Methods: In this study, we examined the risk factors for the recurrence of papillary thyroid carcinoma. We treated 274 patients with thyroid papillary carcinoma at our hospital between 2009 and 2018.

Results: Recurrence occurred in 20 cases (7.3%). Lympho-vascular invasion and lateral cervical lymph node metastasis made significant independent contributions.

Conclusion: The selection of the surgical mode should be based on the recurrence and after comprehensive consideration of the clinical features.

查看原文本刊更多论文

甲状腺乳头状癌复发危险因素的临床研究。

简介:甲状腺乳头状癌是最常见的内分泌恶性肿瘤，也是最常见的甲状腺癌类型，约占所有甲状腺癌病例的85%。通常病程良好，10年生存率超过90%。然而，文献报道首次手术治疗后复发率为7-23%。考虑这种复发的药物治疗策略是很重要的。方法:本研究探讨甲状腺乳头状癌复发的危险因素。2009年至2018年，我院共治疗甲状腺乳头状癌274例。结果:复发20例(7.3%)。淋巴血管浸润和颈侧淋巴结转移是重要的独立贡献。结论:手术方式的选择应根据复发情况，综合考虑临床特点。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Orl-Journal for Oto-Rhino-Laryngology Head and Neck Surgery 医学-耳鼻喉科学

CiteScore

2.80

自引率

7.70%

发文量

审稿时长

6-12 weeks

期刊介绍： ''ORL'' contains concise, original scientific papers of interest for both clinicians and researchers in oto-rhino-laryngology and head and neck surgery. Contributions drawn from the basic sciences cover new knowledge on the anatomy, pathology, pathophysiology, immunology and tumor biology of head and neck and the auditory and vestibular system, the salivary glands, paranasal sinuses and of the organs of the upper respiratory and digestive tract. The practical value of the journal is accentuated by reports of clinical progress in diagnosis and therapy.